CPC Scientific

CDMO specializing in large-scale, late-phase, and commercial GMP peptide and oligonucleotide manufacturing. Annual peptide API production capacity exceeds 1,000 kg. Serves clinical and commercial pharmaceutical clients. New US-based facility opening 2026. Maintains global shipping logistics for multi-kg batches.